Javascript doit fonctionner ! Activez-le et rechargez cette page.
Le Rézo de JeuxDeMots
• Types de relations
• Types de noeuds
• Consolider
le terme
  Options  
             

  Filtrage type relations : +   - (ex: 4, 12, 18, 36, 444, 555, 777)
  Filtrage valeur :          min   max
  Filtrage type noeuds :   +   - (ex: 4, 6, 8, 9, 10, 12, 18, 36, 444, 555, 777)

  Présentation de sortie :   (ex: -rien-, cloud, nicecloud)
 

'en:structure-activity relationship'
(id=6976072 ; fe=en:structure-activity relationship ; type=1 ; niveau=200 ; luminosité=25 ; somme entrante=1023 creation date=2017-06-25 touchdate=2025-11-02 18:08:35.000)
≈ 28 relations sortantes

  1. en:structure-activity relationship -- r_associated #0: 27 / 1 -> en:th1-th2 balance
    n1=en:structure-activity relationship | n2=en:th1-th2 balance | rel=r_associated | relid=0 | w=27
  2. en:structure-activity relationship -- r_associated #0: 23 / 0.852 -> en:drug resistance process
    n1=en:structure-activity relationship | n2=en:drug resistance process | rel=r_associated | relid=0 | w=23
  3. en:structure-activity relationship -- r_associated #0: 22 / 0.815 -> en:drug tolerance
    n1=en:structure-activity relationship | n2=en:drug tolerance | rel=r_associated | relid=0 | w=22
  4. en:structure-activity relationship -- r_associated #0: 20 / 0.741 -> en:base pair
    n1=en:structure-activity relationship | n2=en:base pair | rel=r_associated | relid=0 | w=20
  5. en:structure-activity relationship -- r_associated #0: 20 / 0.741 -> en:binding (molecular function)
    n1=en:structure-activity relationship | n2=en:binding (molecular function) | rel=r_associated | relid=0 | w=20
  6. en:structure-activity relationship -- r_associated #0: 20 / 0.741 -> en:binding sites
    n1=en:structure-activity relationship | n2=en:binding sites | rel=r_associated | relid=0 | w=20
  7. en:structure-activity relationship -- r_associated #0: 20 / 0.741 -> en:brain chemistry
    n1=en:structure-activity relationship | n2=en:brain chemistry | rel=r_associated | relid=0 | w=20
  8. en:structure-activity relationship -- r_associated #0: 20 / 0.741 -> en:chromatin structure
    n1=en:structure-activity relationship | n2=en:chromatin structure | rel=r_associated | relid=0 | w=20
  9. en:structure-activity relationship -- r_associated #0: 20 / 0.741 -> en:depression, chemical
    n1=en:structure-activity relationship | n2=en:depression, chemical | rel=r_associated | relid=0 | w=20
  10. en:structure-activity relationship -- r_associated #0: 20 / 0.741 -> en:drug interaction
    n1=en:structure-activity relationship | n2=en:drug interaction | rel=r_associated | relid=0 | w=20
  11. en:structure-activity relationship -- r_associated #0: 20 / 0.741 -> en:ligands activity
    n1=en:structure-activity relationship | n2=en:ligands activity | rel=r_associated | relid=0 | w=20
  12. en:structure-activity relationship -- r_associated #0: 20 / 0.741 -> en:membrane fluidity
    n1=en:structure-activity relationship | n2=en:membrane fluidity | rel=r_associated | relid=0 | w=20
  13. en:structure-activity relationship -- r_associated #0: 20 / 0.741 -> en:models, chemical
    n1=en:structure-activity relationship | n2=en:models, chemical | rel=r_associated | relid=0 | w=20
  14. en:structure-activity relationship -- r_associated #0: 20 / 0.741 -> en:molecular site
    n1=en:structure-activity relationship | n2=en:molecular site | rel=r_associated | relid=0 | w=20
  15. en:structure-activity relationship -- r_associated #0: 20 / 0.741 -> en:nucleic acid structure
    n1=en:structure-activity relationship | n2=en:nucleic acid structure | rel=r_associated | relid=0 | w=20
  16. en:structure-activity relationship -- r_associated #0: 20 / 0.741 -> en:nucleotide sequence
    n1=en:structure-activity relationship | n2=en:nucleotide sequence | rel=r_associated | relid=0 | w=20
  17. en:structure-activity relationship -- r_associated #0: 20 / 0.741 -> en:peptide bond constituents
    n1=en:structure-activity relationship | n2=en:peptide bond constituents | rel=r_associated | relid=0 | w=20
  18. en:structure-activity relationship -- r_associated #0: 20 / 0.741 -> en:ph homeostasis
    n1=en:structure-activity relationship | n2=en:ph homeostasis | rel=r_associated | relid=0 | w=20
  19. en:structure-activity relationship -- r_associated #0: 20 / 0.741 -> en:polymer
    n1=en:structure-activity relationship | n2=en:polymer | rel=r_associated | relid=0 | w=20
  20. en:structure-activity relationship -- r_associated #0: 20 / 0.741 -> en:protein structure function
    n1=en:structure-activity relationship | n2=en:protein structure function | rel=r_associated | relid=0 | w=20
  21. en:structure-activity relationship -- r_associated #0: 20 / 0.741 -> en:quantitative structure-activity relationship
    n1=en:structure-activity relationship | n2=en:quantitative structure-activity relationship | rel=r_associated | relid=0 | w=20
  22. en:structure-activity relationship -- r_associated #0: 20 / 0.741 -> en:stimulation, chemical
    n1=en:structure-activity relationship | n2=en:stimulation, chemical | rel=r_associated | relid=0 | w=20
  23. en:structure-activity relationship -- r_associated #0: 20 / 0.741 -> interaction médicamenteuse
    n1=en:structure-activity relationship | n2=interaction médicamenteuse | rel=r_associated | relid=0 | w=20
  24. en:structure-activity relationship -- r_associated #0: 20 / 0.741 -> paire de bases
    n1=en:structure-activity relationship | n2=paire de bases | rel=r_associated | relid=0 | w=20
  25. en:structure-activity relationship -- r_associated #0: 20 / 0.741 -> polymer
    n1=en:structure-activity relationship | n2=polymer | rel=r_associated | relid=0 | w=20
  26. en:structure-activity relationship -- r_associated #0: 20 / 0.741 -> séquence nucléotidique
    n1=en:structure-activity relationship | n2=séquence nucléotidique | rel=r_associated | relid=0 | w=20
  27. en:structure-activity relationship -- r_associated #0: 20 / 0.741 -> sites de fixation
    n1=en:structure-activity relationship | n2=sites de fixation | rel=r_associated | relid=0 | w=20
  28. en:structure-activity relationship -- r_associated #0: 20 / 0.741 -> sites de liaison
    n1=en:structure-activity relationship | n2=sites de liaison | rel=r_associated | relid=0 | w=20
≈ 35 relations entrantes

  1. en:binding sites --- r_associated #0: 52 --> en:structure-activity relationship
    n1=en:binding sites | n2=en:structure-activity relationship | rel=r_associated | relid=0 | w=52
  2. sites de liaison --- r_associated #0: 50 --> en:structure-activity relationship
    n1=sites de liaison | n2=en:structure-activity relationship | rel=r_associated | relid=0 | w=50
  3. sites de fixation --- r_associated #0: 46 --> en:structure-activity relationship
    n1=sites de fixation | n2=en:structure-activity relationship | rel=r_associated | relid=0 | w=46
  4. en:ph homeostasis --- r_associated #0: 38 --> en:structure-activity relationship
    n1=en:ph homeostasis | n2=en:structure-activity relationship | rel=r_associated | relid=0 | w=38
  5. paire de bases --- r_associated #0: 37 --> en:structure-activity relationship
    n1=paire de bases | n2=en:structure-activity relationship | rel=r_associated | relid=0 | w=37
  6. en:binding (molecular function) --- r_associated #0: 35 --> en:structure-activity relationship
    n1=en:binding (molecular function) | n2=en:structure-activity relationship | rel=r_associated | relid=0 | w=35
  7. en:chromatin structure --- r_associated #0: 35 --> en:structure-activity relationship
    n1=en:chromatin structure | n2=en:structure-activity relationship | rel=r_associated | relid=0 | w=35
  8. en:stimulation, chemical --- r_associated #0: 35 --> en:structure-activity relationship
    n1=en:stimulation, chemical | n2=en:structure-activity relationship | rel=r_associated | relid=0 | w=35
  9. en:base pair --- r_associated #0: 34 --> en:structure-activity relationship
    n1=en:base pair | n2=en:structure-activity relationship | rel=r_associated | relid=0 | w=34
  10. en:drug resistance process --- r_associated #0: 34 --> en:structure-activity relationship
    n1=en:drug resistance process | n2=en:structure-activity relationship | rel=r_associated | relid=0 | w=34
  11. en:models, chemical --- r_associated #0: 34 --> en:structure-activity relationship
    n1=en:models, chemical | n2=en:structure-activity relationship | rel=r_associated | relid=0 | w=34
  12. en:depression, chemical --- r_associated #0: 32 --> en:structure-activity relationship
    n1=en:depression, chemical | n2=en:structure-activity relationship | rel=r_associated | relid=0 | w=32
  13. en:nucleic acid structure --- r_associated #0: 32 --> en:structure-activity relationship
    n1=en:nucleic acid structure | n2=en:structure-activity relationship | rel=r_associated | relid=0 | w=32
  14. en:membrane fluidity --- r_associated #0: 30 --> en:structure-activity relationship
    n1=en:membrane fluidity | n2=en:structure-activity relationship | rel=r_associated | relid=0 | w=30
  15. en:peptide bond constituents --- r_associated #0: 30 --> en:structure-activity relationship
    n1=en:peptide bond constituents | n2=en:structure-activity relationship | rel=r_associated | relid=0 | w=30
  16. interaction médicamenteuse --- r_associated #0: 30 --> en:structure-activity relationship
    n1=interaction médicamenteuse | n2=en:structure-activity relationship | rel=r_associated | relid=0 | w=30
  17. en:molecular site --- r_associated #0: 29 --> en:structure-activity relationship
    n1=en:molecular site | n2=en:structure-activity relationship | rel=r_associated | relid=0 | w=29
  18. en:nucleotide sequence --- r_associated #0: 29 --> en:structure-activity relationship
    n1=en:nucleotide sequence | n2=en:structure-activity relationship | rel=r_associated | relid=0 | w=29
  19. en:quantitative structure-activity relationship --- r_associated #0: 29 --> en:structure-activity relationship
    n1=en:quantitative structure-activity relationship | n2=en:structure-activity relationship | rel=r_associated | relid=0 | w=29
  20. séquence nucléotidique --- r_associated #0: 29 --> en:structure-activity relationship
    n1=séquence nucléotidique | n2=en:structure-activity relationship | rel=r_associated | relid=0 | w=29
  21. en:drug tolerance --- r_associated #0: 28 --> en:structure-activity relationship
    n1=en:drug tolerance | n2=en:structure-activity relationship | rel=r_associated | relid=0 | w=28
  22. en:ligands activity --- r_associated #0: 28 --> en:structure-activity relationship
    n1=en:ligands activity | n2=en:structure-activity relationship | rel=r_associated | relid=0 | w=28
  23. en:protein structure function --- r_associated #0: 27 --> en:structure-activity relationship
    n1=en:protein structure function | n2=en:structure-activity relationship | rel=r_associated | relid=0 | w=27
  24. en:brain chemistry --- r_associated #0: 26 --> en:structure-activity relationship
    n1=en:brain chemistry | n2=en:structure-activity relationship | rel=r_associated | relid=0 | w=26
  25. en:drug interaction --- r_associated #0: 26 --> en:structure-activity relationship
    n1=en:drug interaction | n2=en:structure-activity relationship | rel=r_associated | relid=0 | w=26
  26. en:polymer --- r_associated #0: 26 --> en:structure-activity relationship
    n1=en:polymer | n2=en:structure-activity relationship | rel=r_associated | relid=0 | w=26
  27. en:th1-th2 balance --- r_associated #0: 26 --> en:structure-activity relationship
    n1=en:th1-th2 balance | n2=en:structure-activity relationship | rel=r_associated | relid=0 | w=26
  28. polymer --- r_associated #0: 26 --> en:structure-activity relationship
    n1=polymer | n2=en:structure-activity relationship | rel=r_associated | relid=0 | w=26
  29. en:carbohydrate sequence --- r_associated #0: 25 --> en:structure-activity relationship
    n1=en:carbohydrate sequence | n2=en:structure-activity relationship | rel=r_associated | relid=0 | w=25
  30. en:conformation --- r_associated #0: 25 --> en:structure-activity relationship
    n1=en:conformation | n2=en:structure-activity relationship | rel=r_associated | relid=0 | w=25
  31. Interaction médicamenteuse --- r_associated #0: 15 --> en:structure-activity relationship
    n1=Interaction médicamenteuse | n2=en:structure-activity relationship | rel=r_associated | relid=0 | w=15
  32. Séquence nucléotidique --- r_associated #0: 15 --> en:structure-activity relationship
    n1=Séquence nucléotidique | n2=en:structure-activity relationship | rel=r_associated | relid=0 | w=15
  33. Pagon (syndrome de) --- r_associated #0: 10 --> en:structure-activity relationship
    n1=Pagon (syndrome de) | n2=en:structure-activity relationship | rel=r_associated | relid=0 | w=10
  34. Paire de bases --- r_associated #0: 10 --> en:structure-activity relationship
    n1=Paire de bases | n2=en:structure-activity relationship | rel=r_associated | relid=0 | w=10
  35. drug interaction --- r_associated #0: 10 --> en:structure-activity relationship
    n1=drug interaction | n2=en:structure-activity relationship | rel=r_associated | relid=0 | w=10
Le service Rézo permet d'énumérer les relations existant pour un terme. Ce service est interrogeable par programme.
Projet JeuxDeMots - url: http://www.jeuxdemots.org
contact: mathieu.lafourcade@lirmm.fr